These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy. Li C; Yang CW; Park JH; Lim SW; Sun BK; Jung JY; Kim SB; Kim YS; Kim J; Bang BK Am J Physiol Renal Physiol; 2004 Jan; 286(1):F46-57. PubMed ID: 14519596 [TBL] [Abstract][Full Text] [Related]
3. Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin). Masumoto A; Hirooka Y; Hironaga K; Eshima K; Setoguchi S; Egashira K; Takeshita A Am J Cardiol; 2001 Dec; 88(11):1291-4. PubMed ID: 11728357 [No Abstract] [Full Text] [Related]
5. Importance of NAD(P)H oxidase-mediated oxidative stress and contractile type smooth muscle myosin heavy chain SM2 at the early stage of atherosclerosis. Itoh S; Umemoto S; Hiromoto M; Toma Y; Tomochika Y; Aoyagi S; Tanaka M; Fujii T; Matsuzaki M Circulation; 2002 May; 105(19):2288-95. PubMed ID: 12010912 [TBL] [Abstract][Full Text] [Related]
7. Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress. Andreadou I; Farmakis D; Prokovas E; Sigala F; Zoga A; Spyridaki K; Papalois A; Papapetropoulos A; Anastasiou-Nana M; Kremastinos DT; Iliodromitis EK Cardiovasc Res; 2012 Jun; 94(3):501-9. PubMed ID: 22411971 [TBL] [Abstract][Full Text] [Related]
8. Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits. Mitani H; Egashira K; Ohashi N; Yoshikawa M; Niwa S; Nonomura K; Nakashima A; Kimura M Pharmacology; 2003 Jul; 68(3):121-30. PubMed ID: 12784083 [TBL] [Abstract][Full Text] [Related]
9. Antioxidants and the bioactivity of endothelium-derived nitric oxide. Tomasian D; Keaney JF; Vita JA Cardiovasc Res; 2000 Aug; 47(3):426-35. PubMed ID: 10963716 [No Abstract] [Full Text] [Related]
10. C-reactive protein: a surrogate marker for atherosclerosis. Davidson J; Rotondo D Curr Opin Lipidol; 2004 Jun; 15(3):365-7. PubMed ID: 15166795 [No Abstract] [Full Text] [Related]
11. [The effects of pravastatin on platelet-derived nitric oxide system in rabbits]. Ma LP; Kang MF; Yin SM; Nie DN; Xie SF; Wu YD; Li YQ; Feng JH; Xu LZ Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):539-42. PubMed ID: 16468331 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide in atherosclerosis. Rekka EA; Chrysselis MC Mini Rev Med Chem; 2002 Dec; 2(6):585-93. PubMed ID: 12370036 [TBL] [Abstract][Full Text] [Related]
13. Endothelial nitric oxide synthase genotype modulates the improvement of coronary blood flow by pravastatin: a placebo-controlled PET study. Kunnas TA; Lehtimäki T; Laaksonen R; Ilveskoski E; Janatuinen T; Vesalainen R; Nuutila P; Karhunen PJ; Knuuti J; Nikkari ST J Mol Med (Berl); 2002 Dec; 80(12):802-7. PubMed ID: 12483466 [TBL] [Abstract][Full Text] [Related]
14. Interactions between nitric oxide and endothelin-1 in vessels from hypercholesterolaemic rabbits. Khan MA; Morgan RJ; Thompson CS; Mikhailidis DP Atherosclerosis; 1999 Nov; 147(1):201. PubMed ID: 10577384 [No Abstract] [Full Text] [Related]
15. Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits. Hayashi T; Sumi D; Juliet PA; Matsui-Hirai H; Asai-Tanaka Y; Kano H; Fukatsu A; Tsunekawa T; Miyazaki A; Iguchi A; Ignarro LJ Cardiovasc Res; 2004 Feb; 61(2):339-51. PubMed ID: 14736551 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. Ozaki M; Kawashima S; Yamashita T; Hirase T; Namiki M; Inoue N; Hirata K; Yasui H; Sakurai H; Yoshida Y; Masada M; Yokoyama M J Clin Invest; 2002 Aug; 110(3):331-40. PubMed ID: 12163452 [TBL] [Abstract][Full Text] [Related]
17. Cholesterol-dependent regulation of nitric oxide production: potential role in atherosclerosis. Coppinger RJ; Baum CL Nutr Rev; 1999 Sep; 57(9 Pt 1):279-82. PubMed ID: 10568338 [TBL] [Abstract][Full Text] [Related]
18. Cracking down on caveolin: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in modulating edothelial cell nitric oxide production. Davis ME; Harrison DG Circulation; 2001 Jan; 103(1):2-4. PubMed ID: 11136674 [No Abstract] [Full Text] [Related]
19. Pravastatin activates platelet nitric oxide synthase (NOS) in patients with type 2 diabetes mellitus and NOS activation is accompanied by serine phosphorylation. Yao K; Xu B; Gao L; Ge JB Chin Med J (Engl); 2005 Oct; 118(19):1654-7. PubMed ID: 16232352 [No Abstract] [Full Text] [Related]
20. Atherosclerosis: cell biology and lipoproteins. Brown AJ Curr Opin Lipidol; 2001 Dec; 12(6):671-3. PubMed ID: 11801868 [No Abstract] [Full Text] [Related] [Next] [New Search]